Live Breaking News & Updates on Russell Cook Max Gould|Page 2
Stay updated with breaking news from Russell cook max gould. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Directorate Changes RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world s leading long-term implantable biostable polymer (Elast-Eon TM), is pleased to announce the appointments, with immediate effect, to the Board of Dr Caroline Stretton, Group Chief Operating Officer of the Company, and Ian Ardill as a Non-Executive Director and Chair of the Audit Committee.
Dr Caroline Stretton who was appointed as Group Chief Operating Officer on 1 April 2020, following the Company s acquisition of RUA Medical Devices Limited ( RUA Medical ), joined RUA Medical in 2018 from prosthetic hand manufacturer, Touch Bionics Limited, where, prior to its sale in 2016 to Icelandic orthotic and prosthetic manufacturer Ossur, she was a key member of the leadership team responsible for Global Manufacturing, Operations, Quality and Customer Support. Previously, Caroline had been employed by a numb ....
RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders.
Furthermore, as announced earlier today the Open Offer closed for acceptances at 11.00 a.m. on 29 December 2020 with final valid applications from Qualifying Shareholders in respect of 831,522 Open Offer Shares. Qualifying Shareholders who have validly applied for Open Offer Shares have received their full Open Offer Entitlement. Applications made under the Excess Application Facility were oversubscribed and have been scaled back pro-rata such that approximately 9.7 per cent. of the Excess Application is satisfied. ....
Open Offer to Qualifying Shareholders to raise up to a further £1.0m Cenkos Securities plc appointed joint broker RUA Life Sciences plc (AIM: RUA or the Company or the Group ), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer, is pleased to announce it has conditionally raised approximately £6.0 million by way of a Placing and Subscription to new and existing investors. Furthermore, to provide Shareholders with the opportunity to also subscribe for new Ordinary Shares, the Company is proposing to raise up to an additional c.£1.0 million by way of an Open Offer made to Qualifying Shareholders. ....